Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Practical management of patients with myelofibrosis receiving ruxolitinib.

Harrison C. et al, (2013), Expert Rev Hematol, 6, 511 - 523

Germline counterparts of oncogenic mutations: who gives a JAK?.

Mead AJ. et al, (2013), Oncotarget, 4, 814 - 815

Impact of isolated germline JAK2V617I mutation on human hematopoiesis.

Mead AJ. et al, (2013), Blood, 121, 4156 - 4165

Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21.

Roy A. et al, (2012), Proc Natl Acad Sci U S A, 109, 17579 - 17584

Dicer is selectively important for the earliest stages of erythroid development.

Buza-Vidas N. et al, (2012), Blood, 120, 2412 - 2416

EMERGENCE OF AN IMMUNE-RESTRICTED PROGENITOR PRIOR TO DEFINITIVE HEMATOPOIETIC STEM CELLS

Boiers C. et al, (2012), EXPERIMENTAL HEMATOLOGY, 40, S58 - S58

Guideline for the diagnosis and management of myelofibrosis

Reilly JT. et al, (2012), British Journal of Haematology, 158, 453 - 471

Allogeneic Stem Cell Transplantation for Myelofibrosis in 2012

Mclornan DP. et al, (2012), British Journal of Haematology, 157, 413 - 425

Germline activating JAK2-mutation in a family with hereditary thrombocytosis

Mead A. et al, (2012), BRITISH JOURNAL OF HAEMATOLOGY, 157, 21 - 21

Germline JAK2 mutation in a family with hereditary thrombocytosis.

Mead AJ. et al, (2012), N Engl J Med, 366, 967 - 969